These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9874846)

  • 1. Monoclonal antibody approved for metastatic breast cancer.
    Oncology (Williston Park); 1998 Dec; 12(12):1727. PubMed ID: 9874846
    [No Abstract]   [Full Text] [Related]  

  • 2. First MAb approved for treatment of metastatic breast cancer.
    Brenner TL; Adams VR
    J Am Pharm Assoc (Wash); 1999; 39(2):236-8. PubMed ID: 10079656
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of metastatic breast cancer to trastuzumab?
    Barnes DM; Miles DW
    Lancet; 2000 Jan; 355(9199):160-1. PubMed ID: 10675110
    [No Abstract]   [Full Text] [Related]  

  • 4. More than one way to look for HER2.
    Check W
    CAP Today; 1999 Mar; 13(3):1, 40-2, 46, passim. PubMed ID: 10350906
    [No Abstract]   [Full Text] [Related]  

  • 5. Reputation and precedent in the bevacizumab decision.
    Carpenter D; Kesselheim AS; Joffe S
    N Engl J Med; 2011 Jul; 365(2):e3. PubMed ID: 21707383
    [No Abstract]   [Full Text] [Related]  

  • 6. Bevacizumab in the treatment of breast cancer.
    Sirohi B; Smith K
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1559-68. PubMed ID: 18925848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipilimumab approved for metastatic melanoma.
    Traynor K
    Am J Health Syst Pharm; 2011 May; 68(9):768. PubMed ID: 21515855
    [No Abstract]   [Full Text] [Related]  

  • 8. Approved agents for metastatic breast cancer.
    Fornier MN
    Semin Oncol; 2011 Jun; 38 Suppl 2():S3-10. PubMed ID: 21600382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac issues related to trastuzumab.
    Perez EA
    Breast; 2004 Jun; 13(3):171-2. PubMed ID: 15177417
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncologic drugs advisory committee recommends withdrawing approval for bevacizumab use in breast cancer treatment.
    Future Oncol; 2010 Sep; 6(9):1374. PubMed ID: 20931736
    [No Abstract]   [Full Text] [Related]  

  • 11. Trastuzumab for early breast cancer.
    Stuart NS; Bishop J; Bale C
    Lancet; 2006 Jan; 367(9505):107-8. PubMed ID: 16413865
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual-action drug approved for use in advanced breast cancer.
    McBride D
    ONS Connect; 2007 Jun; 22(6):19. PubMed ID: 17598617
    [No Abstract]   [Full Text] [Related]  

  • 13. Off-label uses of bevacizumab: breast and lung cancer indications.
    Technol Eval Cent Assess Program Exec Summ; 2006 Oct; 21(8):1-4. PubMed ID: 17061398
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA approves drugs for colorectal cancer, lung cancer.
    FDA Consum; 2007; 41(1):5. PubMed ID: 17354284
    [No Abstract]   [Full Text] [Related]  

  • 15. New breast cancer drug.
    Harv Womens Health Watch; 1998 Nov; 6(3):7. PubMed ID: 9814134
    [No Abstract]   [Full Text] [Related]  

  • 16. Herceptin and early breast cancer: a moment for caution.
    Lancet; 2005 Nov; 366(9498):1673. PubMed ID: 16291043
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA. Once on 'fast track,' avastin now derailed.
    Couzin-Frankel J; Ogale Y
    Science; 2011 Jul; 333(6039):143-4. PubMed ID: 21737712
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenomics at work.
    Nat Biotechnol; 1998 Oct; 16(10):885. PubMed ID: 9788323
    [No Abstract]   [Full Text] [Related]  

  • 19. Berlex Laboratories to market new treatment for B-CLL.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):3. PubMed ID: 12113127
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain metastases in patients receiving trastuzumab for breast cancer.
    Salmaggi A; Silvani A; Boiardi A
    Neurol Sci; 2007 Mar; 28(1):1. PubMed ID: 17385088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.